Director, Alliance Management

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

The Director, Alliance Management will serve as a key liaison between RevMed and its strategic partners, ensuring the success of collaborations across research and development. This role requires a dynamic leader with strong relationship management skills and the ability to drive alignment between internal teams and external stakeholders to achieve shared objectives.

Strategic Partnership Management:

• Oversee a variety of strategic alliances with industry and academic partners to optimize collaboration effectiveness and achieve goals for the alliance. • Serve as the primary RevMed point of contact for these partners.

Stakeholder Engagement:

• Facilitate regular communication between internal teams and external partners through joint governance committees, steering committees, and operational working groups.

Project Coordination:

• Ensure integration of alliance-related activities across R&D, clinical operations, regulatory affairs, and business development functions.

Issue Resolution and Risk Mitigation:

• Identify potential risks in partnership execution and proactively develop mitigation strategies.

Contract and Agreement Oversight:

• Monitor partnership agreements to ensure contractual obligations are met. • Proactively identify potential issues that may arise between the agreement and operationalizing the alliance.

Experience negotiating and interpreting R&D related contracts including licenses, quality, and pharmacovigilance agreements.

Cross-Functional Collaboration:

• Act as a bridge between scientific, clinical, and business teams to drive alignment on strategic objectives.

Required Skills, Experience and Education:

Experience with leading and managing cross-border transactions, including in-licenses and out-licenses for clinical stage drug candidates.

Deep understanding of oncology drug development, clinical trial processes, and regulatory requirements.

Proven track record of managing a variety of partnerships across different stages of drug development and commercialization.

Outstanding verbal and written communication skills to summarize complex information; effectively interacts and influences across functional areas, project teams, and key external stakeholders.

Excellent negotiation and problem-solving skills.

Innovative, proactive, and collaborative team-player with high energy to keep pace with our growing and evolving company environment.

Preferred Skills:

Advanced degree (Ph.D., MBA, M.S., or equivalent) in life sciences, business, or a related field preferred.

#LI-Hybrid #LI-YG1